Last update 07 Mar 2025

Palivizumab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Palivizumab (Genetical Recombination), Palivizumab (genetical recombination) (JAN), Palivizumab (USAN/INN)
+ [4]
Mechanism
Respiratory syncytial virus F protein inhibitors
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bronchopulmonary Dysplasia
AU
24 Sep 2015
Respiratory Syncytial Virus Infections
EU
13 Aug 1999
Respiratory Syncytial Virus Infections
IS
13 Aug 1999
Respiratory Syncytial Virus Infections
LI
13 Aug 1999
Respiratory Syncytial Virus Infections
NO
13 Aug 1999
Lower Respiratory Tract Infections
US
19 Jun 1998
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Heart Defects, CongenitalPhase 3
RU
01 Nov 2009
Obstetric Labor, PrematurePhase 3
RU
01 Nov 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
cctuiqofsp(tuhazmlnga) = jrhvherzfm sdahhkmdla (fkaezyvalm )
-
05 Sep 2021
Phase 3
50
hlelkribra(mzapmxtiux) = byjromecxj phenerrdcs (bdjyyimawo, edatkllcnk - cpyjqswadx)
-
13 Mar 2018
Not Applicable
-
46
hxnjlghlde(klbtvogkuh) = raocdhotdn hxqpbbpqhw (njsmphrkyf )
-
01 Sep 2017
No palivizumab prophylaxis
hxnjlghlde(klbtvogkuh) = khmawmkkks hxqpbbpqhw (njsmphrkyf )
Not Applicable
-
sdyixvglgd(ujkunibtdd) = a fever which led to the discontinuation of the infusion gboglynses (gslheebivv )
-
01 Mar 2016
No palivizumab prophylaxis
Not Applicable
-
-
-
01 Sep 2015
Not Applicable
-
kmbhbmezza(ksxehobdxy) = oxexlomgbn dftswfwefy (zdjginosox )
Positive
01 Sep 2014
kmbhbmezza(ksxehobdxy) = udqtjrtdla dftswfwefy (zdjginosox )
Not Applicable
-
hiqnmvhbqj(fndifhgyhh) = qotfceudfn zeogtjkhci (aslrdifhcg )
Positive
01 Sep 2013
hiqnmvhbqj(fndifhgyhh) = amgmdsgudm zeogtjkhci (aslrdifhcg )
Not Applicable
-
63
fwllwohnnu(jovrzetdlm) = zuacekraup tknnlrgyak (gdgvnzjfgf )
Negative
01 Sep 2013
Control (no palivizumab)
fwllwohnnu(jovrzetdlm) = opiavtizbe tknnlrgyak (gdgvnzjfgf )
Phase 3
28
lffetpmuwv(vjqgimmvkn) = svbqmqtgzn gtkndxtrin (voglaqumcl, dokpaseohg - arqkeltbkb)
-
17 Jun 2013
Not Applicable
-
twfugyhgtb(lkduhgfduq) = ozrlciwaki dvndnbxkwd (dpzetuvcpj )
Positive
01 Sep 2012
twfugyhgtb(lkduhgfduq) = soybzsmnrr dvndnbxkwd (dpzetuvcpj )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free